Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T van Gelder

Showing results (151-160 of 169) with videos related to

Pageof 17
Sort By:
Transplantation|August 10, 1999
A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantationT van Gelder, L B Hilbrands, Y Vanrenterghem, et al.
British Journal of Clinical Pharmacology|December 16, 2018
A population pharmacokinetic model to predict the individual starting dose of tacrolimus in adult renal transplant recipientsL M Andrews, D A Hesselink, R H N van Schaik, et al.
Alimentary Pharmacology & Therapeutics|November 14, 2008
The effects of guideline implementation for proton pump inhibitor prescription on two pulmonary medicine wardsE P M van Vliet, E W Steyerberg, H J A M Otten, et al.
Clinical Pharmacology and Therapeutics|June 5, 2009
UGT1A9 -275T>A/-2152C>T polymorphisms correlate with low MPA exposure and acute rejection in MMF/tacrolimus-treated kidney transplant patientsR H N van Schaik, M van Agteren, J W de Fijter, et al.
Transplantation|April 13, 1999
Anti-CD25 therapy reveals the redundancy of the intragraft cytokine network after clinical heart transplantationC C Baan, C J Knoop, T van Gelder, et al.
The New England Journal of Medicine|December 3, 1998
The effect of tolerance to noninherited maternal HLA antigens on the survival of renal transplants from sibling donorsW J Burlingham, A P Grailer, D M Heisey, et al.
Transplantation|June 5, 2003
Anti-CD25 monoclonal antibody therapy affects the death signals of graft-infiltrating cells after clinical heart transplantationC C Baan, A H M M Balk, I C van Riemsdijk, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 30, 2015
A Randomized Controlled Trial Comparing the Efficacy of Cyp3a5 Genotype-Based With Body-Weight-Based Tacrolimus Dosing After Living Donor Kidney TransplantationN Shuker, R Bouamar, R H N van Schaik, et al.
Frontiers in Pharmacology|May 17, 2021
Policy and Practice Review: A First Guideline on the Use of Pharmacogenetics in Clinical Psychiatric PracticeR van Westrhenen, R H N van Schaik, T van Gelder, et al.
The Pharmacogenomics Journal|November 4, 2009
The CYP2C19*17 genotype is associated with lower imipramine plasma concentrations in a large group of depressed patientsP W Schenk, M van Vliet, R A A Mathot, et al.
Pageof 17

Showing results (151-160 of 169) with videos related to

Sort By:
Pageof 17
Transplantation|August 10, 1999
A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantationT van Gelder, L B Hilbrands, Y Vanrenterghem, et al.
British Journal of Clinical Pharmacology|December 16, 2018
A population pharmacokinetic model to predict the individual starting dose of tacrolimus in adult renal transplant recipientsL M Andrews, D A Hesselink, R H N van Schaik, et al.
Alimentary Pharmacology & Therapeutics|November 14, 2008
The effects of guideline implementation for proton pump inhibitor prescription on two pulmonary medicine wardsE P M van Vliet, E W Steyerberg, H J A M Otten, et al.
Clinical Pharmacology and Therapeutics|June 5, 2009
UGT1A9 -275T>A/-2152C>T polymorphisms correlate with low MPA exposure and acute rejection in MMF/tacrolimus-treated kidney transplant patientsR H N van Schaik, M van Agteren, J W de Fijter, et al.
Transplantation|April 13, 1999
Anti-CD25 therapy reveals the redundancy of the intragraft cytokine network after clinical heart transplantationC C Baan, C J Knoop, T van Gelder, et al.
The New England Journal of Medicine|December 3, 1998
The effect of tolerance to noninherited maternal HLA antigens on the survival of renal transplants from sibling donorsW J Burlingham, A P Grailer, D M Heisey, et al.
Transplantation|June 5, 2003
Anti-CD25 monoclonal antibody therapy affects the death signals of graft-infiltrating cells after clinical heart transplantationC C Baan, A H M M Balk, I C van Riemsdijk, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 30, 2015
A Randomized Controlled Trial Comparing the Efficacy of Cyp3a5 Genotype-Based With Body-Weight-Based Tacrolimus Dosing After Living Donor Kidney TransplantationN Shuker, R Bouamar, R H N van Schaik, et al.
Frontiers in Pharmacology|May 17, 2021
Policy and Practice Review: A First Guideline on the Use of Pharmacogenetics in Clinical Psychiatric PracticeR van Westrhenen, R H N van Schaik, T van Gelder, et al.
The Pharmacogenomics Journal|November 4, 2009
The CYP2C19*17 genotype is associated with lower imipramine plasma concentrations in a large group of depressed patientsP W Schenk, M van Vliet, R A A Mathot, et al.
Pageof 17